MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer

European Journal of Human Genetics

Volumn 17, Issue 5, 2009, Pages 629-635

  Reeves, Stuart G ^a   Meldrum, Cliff ^b   Groombridge, Claire ^c   Spigelman, Allan D ^c   Suchy, Janina ^d   Kurzawski, Grzegorz ^d   Lubinski, Jan ^d   McElduff, Patrick ^a   Scott, Rodney J ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c HUNTER NEW ENGLAND HEALTH   (Australia)

^d International Hereditary Cancer Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOSINE; GUANINE; PROTEIN MLH1; PROTEIN MSH2; THYMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME; WILD TYPE;

ADULT; AGE OF ONSET; ALLELES; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 67349113782     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.239     Document Type: Article

References (23)

1. de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4: 769-780.
2. Peltomaki P: Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 2001; 10: 735-740.
3. Scott RJ, McPhillips M, Meldrum C et al: Hereditary nonpolyposis colorectal cancer in 95 families: Differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001; 8: 118-127.
4. Alarcon F, Lasset C, Carayol J et al: Estimating cancer risk in HNPCC by the GRL method. Eur J Hum Genet 2007; 15: 831-836.
5. Aaltonen LA, Salovaara R, Kristo P et al: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-1487.
6. Samowitz WS, Curtin K, Lin HH et al: The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001; 121: 830-838.
7. DeFrancisco J, Grady WM: Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc 2003; 58: 390-408.
8. Plaschke J, Schwanebeck U, Pistorius S, Saeger HD, Schackert HK: Methylenetetrahydrofolate reductase polymorphisms and risk of sporadic and hereditary colorectal cancer with or without microsatellite instability. Cancer Lett 2003; 191: 179-185.
9. Brockton NT: LoTalized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? Cancer Causes Control 2006; 17: 1005-1016.
10. Blount BC, Mack MM, Wehr CM et al: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94 3290-3295.
11. Stern LL, Mason JB, Selhub J, Choi SW: Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the 677C>T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000; 9: 849-853.
12. van der Put NM, Gabreels F, Stevens EMB et al: A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62 1044-1051.
13. Weisberg I, Tran P, Christensen B, Sibani R, Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172.
14. Weisberg IS, Jacques PF, Selhub J et al: The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409-415.
15. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A: B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002; 13: 239-248.
16. Mitrou PN, Watson MA, Loktionov AS et al: MTHFR (677C>T and 1298A>C) polymorphisms and risk of sporadic distal colorectal adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom). Cancer Causes Control 2006; 17: 793-801.
17. Hubner RA, Houlston RS: MTHFR 677C>A and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer 2007; 120: 1027-1035.
18. Pande M, Chen J, Amos CI, Lynch PM, Broaddus R, Frazier ML: Influence of methylenetetrahydrofolate reductase gene polymorphisms 677C>T and 1298A>C on age-associated risk for colorectal cancer in a Caucasian lynch syndrome population. Cancer Epidemiol Biomarkers Prev 2007; 16: 1753-1759.
19. Frosst P, Blom HJ, Milos R et al: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
20. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokaosch G: Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43: 414-421.
21. Shan X, Wang L, Hoffmaster R, Kruger WD: Functional characterization of human methylenetetrahydrofolate reductase in Saccharomyces cerevisiae. J Biol Chem 1999; 274: 32613-32618.
22. Tregouet D-A, Tiret L: Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm. Eur J Hum Genet 2004; 12: 971-974.
23. Kim YI: Folate and colorActal cancer: an evidence-based critical review. Mol Nutr Food Res 2007; 51: 267-292.